作者：
Long, G. V. [1]
;
Hauschild, A. [2]
;
Santinami, M. [3]
;
Atkinson, V. [4]
;
Mandala, M. [5]
;
Chiarion-Sileni, V. [6]
;
Larkin, J. [7]
;
Nyakas, M. [8]
;
Dutriaux, C. [9]
;
Haydon, A. [10]
;
Robert, C. [11]
;
Mortier, L. [12]
;
Schachter, J. [13]
;
Schadendorf, D. [14]
;
Lesimple, T. [15]
;
Plummer, R. [16]
;
Ji, R. [17]
;
Zhang, P. [18]
;
Mookerjee, B. [19]
;
Legos, J. [20]
;
Kefford, R. ;
Dummer, R. ;
Kirkwood, J. M.
作者单位：
Sheba Med Ctr, Ella Inst Melanoma, Tel Hashomer, Israel
[1]
Univ Queensland, Princess Alexandra Hosp, Gallipoli Med Res Fdn, Brisbane, Qld, Australia
[2]
Univ Pittsburgh, Hillman UPMC Canc Ctr, Melanoma Program, Pittsburgh, PA USA
[3]
Novartis Pharmaceut, E Hanover, NJ USA
[4]
Univ Sydney, Macquarie Univ, Melanoma Inst Australia, Sydney, NSW, Australia
[5]
Ctr Eugene Marquis, Dept Med Oncol, Rennes, France
[6]
Univ Hosp Essen, Essen, Germany
[7]
Papa Giovanni XXIII Canc Ctr Hosp, Bergamo, Italy
[8]
Univ Hosp Zurich Skin Canc Ctr, Zurich, Switzerland
[9]
Univ Hosp Schleswig Holstein, Kiel, Germany
[10]
Royal Marsden NHS Fdn Trust, London, England
[11]
Inst Gustave Roussy, Paris, France
[12]
Fdn Ist Nazl Tumori, Milan, Italy
[13]
Radiumhosp, Rikshosp, Oslo, Norway
[14]
Univ Lille, Ctr Hosp Reg Univ Lille, INSERM, Unite 1189, Lille, France
[15]
Freeman Rd Hosp, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, England
[16]
Univ Sydney, Royal North Shore & Mater Hosp, Melanoma Inst Australia, Sydney, NSW, Australia
[17]
Hop St Andre, Ctr Hosp Univ Bordeaux, Bordeaux, France
[18]
Veneto Oncol Inst, Melanoma Oncol Unit, Padua, Italy
[19]
Alfred Hosp, Melbourne, Vic, Australia
[20]
发布时间
2018-04-25
换一批
